Infinity Pharmaceuticals, Inc. Highlights Broad Expansion of Hsp90 Clinical Program and Announces Fourth Quarter Financial Results

CAMBRIDGE, Mass., Feb. 13, 2008 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today provided a research and development update and announced financial results for the fourth quarter of 2007.